Cargando…
Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris
Candida auris is an emerging yeast pathogen of candidemia with the ability to develop resistance to all current antifungal drug classes. Novel antifungal therapies against C. auris are warranted. NSC319726 is a thiosemicarbazone with an inhibitory effect on fungal ribosome biogenesis that has demons...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567239/ https://www.ncbi.nlm.nih.gov/pubmed/34730380 http://dx.doi.org/10.1128/Spectrum.01395-21 |